Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Sep;12(3):390–394. doi: 10.1128/aac.12.3.390

Comparative Study of Trichothecin, Amphotericin B, and 5-Fluorocytosine Against Cryptococcus neoformans In Vitro and In Vivo

M R Sneller 1,†, A Hariri 1, W G Sorenson 1, H W Larsh 1
PMCID: PMC429923  PMID: 334065

Abstract

Trichothecin (T-cin), amphotericin B (AB), and 5-fluorocytosine (FC) were compared singly and in combination for capacities to inhibit growth of Cryptococcus neoformans in culture and to protect mice bearing infections with this yeast. The minimum inhibitory concentrations for T-cin, AB, and FC were found to be 0.5, 0.2, and 5.0 μg/ml, respectively. In vitro viability studies demonstrated a marked reduction in colony counts with the AB-FC combination and additive effects with the AB–T-cin and FC–T-cin combinations for a 3-day period. In mice infected intravenously with C. neoformans, the mean effective dose for AB was 0.38 mg/kg, and for FC it was 100 mg/kg for a 30-day treatment period. No mean effective dose could be ascertained when T-cin was tested at doses of 0.1 to 50 mg/kg. Despite this, marked beneficial effects were noted in vivo with the AB–T-cin combination, whereas additive effects and indifference were observed for AB-FC and FC–T-cin combinations, respectively. High-dose T-cin controls survived despite having received a cumulative dosage of more than twice the reported (LD50) mean lethal dose value.

Full text

PDF
390

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Block E. R., Jennings A. E., Bennett J. E. Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine. Antimicrob Agents Chemother. 1973 Oct;4(4):392–395. doi: 10.1128/aac.4.4.392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cundliffe E., Cannon M., Davies J. Mechanism of inhibition of eukaryotic protein synthesis by trichothecene fungal toxins. Proc Natl Acad Sci U S A. 1974 Jan;71(1):30–34. doi: 10.1073/pnas.71.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. FREEMAN G. G. Further biological properties of trichothecin, an antifungal substance from Trichothecium roseum Link, and its derivatives. J Gen Microbiol. 1955 Apr;12(2):213–221. doi: 10.1099/00221287-12-2-213. [DOI] [PubMed] [Google Scholar]
  4. GLAZ E. T., SCHEIBER E., JARFAS K. Studies on a new antifungal antibiotic. Acta Physiol Acad Sci Hung. 1960;18:225–232. [PubMed] [Google Scholar]
  5. Glaz E. T., Csanyi E., Gyimesi J. Supplementary data on crotocin--an antifungal antibiotic. Nature. 1966 Nov 5;212(5062):617–618. doi: 10.1038/212617b0. [DOI] [PubMed] [Google Scholar]
  6. HORVATH I., VARGA J. M. Enzymic inactivation of trichothecin and crotocin. Nature. 1961 Oct 7;192:88–88. doi: 10.1038/192088a0. [DOI] [PubMed] [Google Scholar]
  7. Hamilton J. D., Elliott D. M. Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice. J Infect Dis. 1975 Feb;131(2):129–137. doi: 10.1093/infdis/131.2.129. [DOI] [PubMed] [Google Scholar]
  8. JAWETZ E., GUNNISON J. B. Antibiotic synergism and antagonism; an assessment of the problem. Pharmacol Rev. 1953 Jun;5(2):175–192. [PubMed] [Google Scholar]
  9. Jawetz E. Combined antibiotic action: some definitions and correlations between laboratory and clinical results. Antimicrob Agents Chemother (Bethesda) 1967;7:203–209. doi: 10.1128/AAC.7.2.203. [DOI] [PubMed] [Google Scholar]
  10. Kosuri N. R., Smalley E. B., Nichols R. E. Toxicologic studies of Fusarium tricinctum (Corda) Snyder et Hansen from moldy corn. Am J Vet Res. 1971 Nov;32(11):1843–1850. [PubMed] [Google Scholar]
  11. Lindenfelser L. A., Lillehoj E. B., Burmeister H. R. Aflatoxin and trichothecene toxins: skin tumor induction and synergistic acute toxicity in white mice. J Natl Cancer Inst. 1974 Jan;52(1):113–116. doi: 10.1093/jnci/52.1.113. [DOI] [PubMed] [Google Scholar]
  12. Medoff G., Comfort M., Kobayashi G. S. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc Soc Exp Biol Med. 1971 Nov;138(2):571–574. doi: 10.3181/00379727-138-35943. [DOI] [PubMed] [Google Scholar]
  13. SCHEIBER E., KAKOSY T., GLAZ E. T. Effect of antifungal agents on the faecal yeast flora of mice. Acta Microbiol Acad Sci Hung. 1961;8:173–179. [PubMed] [Google Scholar]
  14. Shadomy S. In vitro studies with 5-fluorocytosine. Appl Microbiol. 1969 Jun;17(6):871–877. doi: 10.1128/am.17.6.871-877.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sorenson W. G., Sneller M. R., Larsh H. W. Qualitative and quantitative assay of trichothecin: a mycotoxin produced by Trichothecium roseum. Appl Microbiol. 1975 May;29(5):653–657. doi: 10.1128/am.29.5.653-657.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Titsworth E., Grunberg E. Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice. Antimicrob Agents Chemother. 1973 Sep;4(3):306–308. doi: 10.1128/aac.4.3.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wei C. M., McLaughlin C. S. Structure-function relationship in the 12,13-epoxytrichothecenes. Novel inhibitors of protein synthesis. Biochem Biophys Res Commun. 1974 Apr 8;57(3):838–844. doi: 10.1016/0006-291x(74)90622-6. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES